Brigit Biofarmaka Teknologi Tbk. vs Transcoal Pacific Tbk. — how do they compare? Brigit Biofarmaka Teknologi Tbk. trades at Rp236 (market cap 164.65B, 62.5K 24h volume), while Transcoal Pacific Tbk. trades at Rp3,600 (market cap 17.8T, 471.8K 24h volume). The key difference: Transcoal Pacific Tbk. is far larger — about 108.1× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Transcoal Pacific Tbk. is more actively traded (471.8K versus 62.5K). Which is the better fit depends on your goals.
| OBAT | TCPI | |
|---|---|---|
Market Cap | 164.65B | 17.8T |
Volume | 62.5K | 471.8K |
Lot | 625 | 4.72K |
Turnover | 15.03M | 1.69B |
Average Price | 240.55 | 3,588.7 |
Value | 15.03M | 1.69B |
Indicative Equilibrium Price | 238 | 3,600 |
Indicative Equilibrium Volume | 100 | 169 |
Trailing returns across standard periods
Latest headlines on both assets
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →PT Transcoal Pacific Tbk (the Company) was established on 15 January 2007 by deed No. 2 of Maria Regina Tjendra Salim SH., Notary in Jakarta.
Read more on TCPI →